Back to HomeBeta

ICD-10 Coding for Non-Small Cell Lung Cancer(C34.1, M8046/3)

Complete ICD-10-CM coding and documentation guide for Non-Small Cell Lung Cancer. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

NSCLCNon-Small Cell Carcinoma of Lung

Related ICD-10 Code Ranges

Complete code families applicable to Non-Small Cell Lung Cancer

C34.0-C34.9Primary Range

Malignant neoplasm of bronchus and lung

This range covers all primary malignant neoplasms of the lung, including specific lobes and unspecified sites.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C34.1Malignant neoplasm of upper lobe, bronchus or lungUse when a malignant neoplasm is confirmed in the upper lobe of the lung.
  • Histopathology confirming adenocarcinoma or squamous cell carcinoma
  • Imaging showing mass in upper lobe
M8046/3Non-small cell carcinoma, NOSUse only when no specific subtype can be determined.
  • Pathology report indicating NSCLC without further subtyping

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for non-small cell lung cancer

Essential facts and insights about Non-Small Cell Lung Cancer

The ICD-10 code for non-small cell lung cancer varies by lobe, such as C34.1 for the upper lobe.

Primary ICD-10-CM Codes for non-small cell lung cancer

Malignant neoplasm of upper lobe, bronchus or lung
Non-billable Code

Decision Criteria

clinical Criteria

  • Confirmed diagnosis of malignant neoplasm in the upper lobe

Applicable To

  • Adenocarcinoma of upper lobe
  • Squamous cell carcinoma of upper lobe

Excludes

  • Benign neoplasms of lung

Clinical Validation Requirements

  • Histopathology confirming adenocarcinoma or squamous cell carcinoma
  • Imaging showing mass in upper lobe

Code-Specific Risks

  • Misclassification if laterality is not specified

Coding Notes

  • Ensure documentation specifies the lobe and histologic type.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Encounter for antineoplastic chemotherapy

Z51.11
Use when the patient is receiving chemotherapy for NSCLC.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Malignant neoplasm of lower lobe, bronchus or lung

C34.3
Use C34.3 if the tumor is located in the lower lobe.

Adenocarcinoma

M8140/3
Use M8140/3 if adenocarcinoma is confirmed.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Non-Small Cell Lung Cancer to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C34.1.

Impact

Clinical: May lead to inappropriate treatment decisions., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims due to lack of specificity.

Mitigation Strategy

Educate clinicians on documentation standards, Implement checklist for cancer documentation

Impact

Reimbursement: May lead to incorrect billing and reimbursement issues., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of clinical data.

Mitigation Strategy

Always use the specific histology code if available.

Impact

Risk of audits if NSCLC is coded without specific histology.

Mitigation Strategy

Ensure pathology reports are detailed and specific.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Non-Small Cell Lung Cancer, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Non-Small Cell Lung Cancer

Use these documentation templates to ensure complete and accurate documentation for Non-Small Cell Lung Cancer. These templates include all required elements for proper coding and billing.

Pathology report for NSCLC

Specialty: Pathology

Required Elements

  • Specimen site
  • Histologic type
  • Differentiation
  • Molecular markers

Example Documentation

Specimen site: Right upper lobe. Histologic type: Adenocarcinoma. Differentiation: Moderate. Molecular markers: EGFR positive.

Examples: Poor vs. Good Documentation

Poor Documentation Example
NSCLC in lung.
Good Documentation Example
Adenocarcinoma of right upper lobe, confirmed by biopsy.
Explanation
The good example specifies the histologic type and location, improving specificity.

Need help with ICD-10 coding for Non-Small Cell Lung Cancer? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more